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1. Introduction  
Tuberculosis (TB) caused by Mycobacterium tuberculosis (M. tuberculosis) is one of the leading 
reason of mortality and is still spread worldwide, indicated by more than 9 million incident 
cases of TB in 2009 (World Health Organization, 2010). Current standard treatment regimens 
of TB are severely hampered by multidrug resistant tuberculosis (MDR-TB), extensively 
drug-resistant tuberculosis (XDR-TB) and HIV co-infection with TB (WHO, 2010). This fact 
prompts the research to develop novel and more potent drug candidates to treat M. 
tuberculosis strains resistant to existing drugs. The enoyl acyl carrier protein reductase 
(InhA) of M. tuberculosis catalyzing the NADH-specific reduction of 2-trans-enoyl-ACP 
(Quemard et al., 1995) is an attractive target for designing novel antibacterial agents 
(Campbell et al., 2001; Heath et al., 2004; White et al., 2005; Zhang et al., 2004; Wen et al., 
2009; Wright et al., 2007). InhA has been identified as the primary target of isoniazid (INH), 
one of the most effective first-line anti-TB drugs (Rozwarski et al., 1998; Vilcheze et al., 2006; 
Dessen et al., 1995; Lei et al., 2000; Johnsson et al., 1995; Quemard et al., 1996). InhA is 
inhibited by the active adduct of INH (INH-NAD) (Timmins et al., 2006; Johnsson et al., 
1997) which is covalently formed between NAD+ and the reactive acyl radical of INH 
generated by the activation of catalase-peroxidase (KatG) (Saint-Joanis et al., 1999; Zhao et 
al., 2006; Metcalfe et al., 2008; Sinha et al., 1983; Nguyen et al., 2001; Heym et al., 1993; 
Johnsson et al., 1994). The mutations in KatG have been linked to the major mechanism of 
INH resistance ( de la Iglesia et al., 2006; Banerjee et al., 1994). To overcome the INH 
resistance associated with mutations in KatG, compounds that directly inhibit the InhA 
enzyme without requiring activation of KatG have been developed as new promising agents 
against tuberculosis (Freundlich et al., 2009; am Ende et al., 2008; Boyne et al., 2007; Sullivan 
et al., 2006; He et al., 2006; He et al., 2007; Kuo et al., 2003). Triclosan, 5-chloro-2-(2,4-
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dichlorophenoxy)phenol as shown in Fig.1,  has been shown to inhibit InhA without the 
requirement for KatG-mediated activation (Parikh et al., 2000; Kuo et al., 2003). Because of 
the remarkable properties of triclosan, a series of triclosan derivatives with modifications at 
the 5-chloro of triclosan, 5-substituted triclosan derivatives shown in Fig.1, was synthesized 
in order to optimize the potency of triclosan against InhA (Freundlich et al., 2009). 
Furthermore, using structure-based drug design, three lipophilic chlorine atoms of triclosan 
were removed, and one chlorine atom of ring A was replaced by an alkyl chain of varying 
length resulting in the alkyl diphenyl ethers shown in Fig. 1 (Sullivan et al., 2006). The most 
efficacious triclosan derivatives in the two classes of 5-substituted triclosan and alkyl 
diphenyl ether derivatives are more potent than the parent compound triclosan. 
Importantly, a subset of these triclosan analogues displays high efficacy against both INH-
sensitive and INH-resistant strains of M. tuberculosis more than those of isoniazid. Because 
of the remarkable property of 5-substituted triclosan derivatives and alkyl diphenyl ethers, 
their structural requirements for a better therapeutic activity against tuberculosis in both 
cases of drug-sensitive and drug-resistant strains of M. tuberculosis are fascinating and need 
to be thoroughly examined. Therefore, in the present study, a structure based drug design 
using molecular docking calculations was applied to investigate the important drug-enzyme 
interactions of 5-substituted triclosan derivatives and the related alkyl diphenyl ethers in the 
InhA binding pocket. Moreover, approaches based on 2D and 3D QSAR methods, HQSAR 
(Hologram QSAR), CoMFA (Comparative Molecular Field Analysis) and CoMSIA  
(Comparative Molecular Similarity Indices Analysis) (Cramer et al., 1998; Klebe et al., 1994; 
Tong et al., 1998) have been used to elucidate the relationship between the structures and 
the activities of these compounds. A powerful guideline for designing novel and highly 
effective antitubercular agents is the consequence of these investigations.   
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Fig. 1. The chemical structures of triclosan and its derivatives  
2. Materials and methods of calculations 
2.1 Data sets and InhA inhibitory activity  
Chemical structures and experimental biological activities expressed as IC50 (the half 
maximal inhibitory concentration) of 17 compounds of 5-substituted triclosan derivatives 
(Freundlich et al., 2009) and 12 alkyl diphenyl ether derivatives (am Ende et al., 2008; 
Sullivan et al., 2006) were selected for the present study. All chemical structures of these 
compounds were constructed using standard tools available in GaussView 3.07 program 
(Gaussian, Inc., 2006) and were then fully optimized using an ab initio quantum chemical 
method (HF/3-21G) implemented in the Gaussian 03 program (Gaussian, Inc., 2004). The 
compounds were divided into a training set of 25 compounds and a test set of 4 compounds 
for the model development and model validation, respectively. The representatives of the 
test set were manually selected and are covering the utmost range of activity and structural 
diversity of direct InhA inhibitors in the data set.  
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Cpd. R1 R2 R3 R4 IC50 [nM] Log(1/ IC50) 
1 Cl Cl H Cl 1100 2.96 
2* CH3 Cl H Cl 800 3.10 
3 CH2(C6H11) Cl H Cl 110 3.96 
4 CH2CH3 Cl H Cl 120 3.92 
5 (CH2)2CH3 Cl H Cl 91 4.04 
6* (CH2)3CH3 Cl H Cl 55 4.26 
7 CH2CH(CH3)2 Cl H Cl 96 4.02 
8 (CH2)2CH(CH3)2 Cl H Cl 63 4.20 
9 CH2CH(CH3)CH2CH3 Cl H Cl 130 3.89 
10 CH2(2-pyridyl) Cl H Cl 29 4.54 
11 CH2(3-pyridyl) Cl H Cl 42 4.38 
12 CH2(4-pyridyl) Cl H CN 75 4.12 
13 o-CH3-C6H5 Cl H Cl 1300 2.89 
14 m-CH3-C6H5 Cl H Cl 870 3.06 
15 CH2C6H5 Cl H Cl 51 4.29 
16 (CH2)2C6H5 Cl H Cl 21 4.68 
17 (CH2)3C6H5 Cl H Cl 50 4.30 
18 (CH2)5CH3 H H H 11 4.96 
19 CH2CH3 H H H 2000 2.70 
20* (CH2)3CH3 H H H 80 4.10 
21 (CH2)4CH3 H H H 17 4.77 
22 (CH2)7CH3 H H H 5 5.30 
23 (CH2)13CH3 H H H 150 3.82 
24* (CH2)5CH3 NO2 H H 180 3.74 
25 (CH2)5CH3 H NO2 H 48 4.32 
26 (CH2)5CH3 H H NO2 90 4.05 
27 (CH2)5CH3 NH2 H H 62 4.21 
28 (CH2)5CH3 H NH2 H 1090 2.96 
29 (CH2)5CH3 H H NH2 55 4.26 
*The test set compounds 
Table 1. The chemical structures and IC50 values of 5-substituted triclosan and alkyl 
diphenyl ether derivatives against InhA  
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2.2 Molecular docking calculations  
The X-ray crystal structures of InhA complexed with 2-(2,4-dichlorophenoxy)-5-(2-
phenylethyl)phenol (5-substituted triclosan derivative) and 5-octyl-2-phenoxyphenol (alkyl 
diphenyl ether derivative) with pdb codes of 3FNH and 2B37, respectively, were employed 
for molecular docking calculations of compounds 1-17 and compounds 18-29, respectively. 
Docking calculations of the data set were carried out by the Autodock 3.05 program using 
Lamarckian Genetic Algorithm (LGA) (Morris et al., 1998). Docking parameters were used 
as default values, except for the number of docking runs which was set to 50. The docking 
calculation was validated by reproducing the X-ray conformation of the ligand as well as the 
orientation in its pocket. The root mean-square deviation (RMSD) value between the 
original and docked coordinates lower than 1Å is acceptable. The ligand pose with the 
lowest final docked energy was selected as the best binding mode of 5-substituted triclosan 
and alkyl diphenyl ether derivatives. Then, the conformations of all compounds were used 
according to this binding mode for CoMFA and CoMSIA setups.  
2.3 CoMFA and CoMSIA techniques  
CoMFA and CoMSIA, 3D-QSAR methods, are successfully used to derive a correlation 
between the biological activities of a set of compounds with a special alignment and their 
three-dimensional descriptors. In both CoMFA and CoMSIA, a set of compounds is aligned 
and the structurally aligned molecules are represented in terms of fields around the 
molecule (three-dimensional descriptors). CoMFA and CoMSIA are based on the 
assumption that changes in biological activities of compounds are related to changes in 
molecular properties represented by fields around the molecule. Therefore, the structural 
alignment of compounds is an important prerequisite for the setup of appropriate CoMFA 
and CoMSIA models. In the present study, the reasonable binding modes of the compounds 
in the data set obtained from the validated docking calculations were employed for the 
molecular alignment. SYBYL 8.0 molecular modeling software (Tripos, Inc, 2007) was used 
to construct CoMFA and CoMSIA models. CoMFA descriptors, steric and electrostatic 
fields, were calculated using a sp3 carbon probe atom with a formal charge of +1 which was 
placed at the intersections in a grid with the spacing of 2Å. The maximum steric and 
electrostatic energies were truncated at 30 kcal/mol. Five CoMSIA descriptors, steric, 
electrostatic, hydrophobic, hydrogen bond donor and hydrogen bond acceptor fields, were 
derived with the same grid as used for the CoMFA field calculation. There are no energy 
cutoffs necessary for CoMSIA calculations because a distance-dependent Gaussian type 
potential was used in contrary to the procedure of CoMFA calculations. CoMFA and 
CoMSIA descriptors were set as independent variables and log (1/IC50) values were used as 
dependent variables in the partial least square (PLS) analysis to derive a linear relationship 
between molecular descriptors and activities. The cross-validation was performed using the 
leave-one-out method with a 2.0 kcal/mol column filter to minimize the influence of noisy 
columns. A final non cross-validated analysis with the optimal number of components was 
sequentially performed and was then employed to analyze the results. The non-cross-
validated correlation coefficient (r2) and the leave-one-out (LOO) cross-validated correlation 
coefficient (q2) were used to evaluate the predictive ability of the CoMFA and CoMSIA 
models. Contour maps were created to visualize the molecular areas responsible for the 
biological effects.  
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2.4 HQSAR  
Hologram QSAR (HQSAR) does not require information about the three-dimensional 
geometry of the inhibitors. Hence, in contrary to CoMFA and CoMSIA methods, HQSAR 
needs no molecular alignment. Each compound of the data set was converted into all 
possible molecular fragments including linear, branched, cyclic, and overlapping fragments 
in the size of 4-7 atoms. Molecular fragment generation utilizes the fragment distinction 
parameters including atoms (A), bonds (B), connections (C), hydrogen atoms (H), chirality 
(Ch) as well as hydrogen donor and acceptor properties (DA). The generated molecular 
fragments are counted in bins of a fixed length array to produce a molecular hologram. PLS 
statistical method was employed to establish a correlation of the molecular hologram 
descriptors with the biological data. The HQSAR module of SYBYL 8.0 was employed for 
the HQSAR study. The same training and test sets as for CoMFA and CoMSIA studies were 
used. The most convenient model was selected based on the best cross-validated r2 to 
determine these structural subunits which are important for the biological activities.  
3. Result and discussion  
3.1 The X-ray crystal structures of 5-substituted triclosan and alkyl diphenyl ether 
derivatives  
To probe the interaction of 5-substituted triclosan and alkyl diphenyl ether derivatives with 
InhA, the X-ray crystal structures of these compounds complexed with InhA have been 
solved (Freundlich et al., 2009; Sullivan et al., 2006). To compare the conformational change 
of InhA complexed with the different ligands, the ligand-unbound InhA (pdb code 1ENY) 
and InhA bound with 2-(2,4-dichlorophenoxy)-5-(2-phenylethyl)phenol (pdb code 3FNH) 
and 5-octyl-2-phenoxyphenol (pdb code 2B37), compounds 16 and 22, respectively, are 
superimposed as shown in Fig. 2.  
 
 
 
 
 
Fig. 2. Superimposition of ligand unbound InhA, InhA bound with compound 16 (cyan) and 
compound 22 (yellow) with pdb codes of 1ENY, 3FNH and 2B37, respectively. InhAs are 
colored by purple, whereas residues 96-105, 148-168 and 195-225 complexed with 
compounds 16 and 22 are colored by cyan and yellow, respectively. 
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The binding residues within 6Å apart from compounds 16 and 22 consist of residues 96-105, 
148-168 and 195-225. As compared with the ligand-unbound InhA, only positions of residues 
195-225 including two α-helixes and one loop of the InhA bound with compounds 16 and 22 
have been changed to accommodate the binding of two different ligands. On the other hand, 
the binding residues 96-105 and 148-168 of the InhA bound with these compounds are located 
in the same position compared to those of the ligand-unbound InhA as shown in Fig. 2. These 
results imply that residues 195-225 could be sufficiently flexible for the binding of different 
ligands, whereas residues 96-105 and 148-168 are more rigid, which are consistent with the 
mobility of these residues investigated by means of molecular dynamics simulations 
performed in one of our previous investigations (Punkvang et al., 2010). With regard to the 
binding modes of compounds 16 and 22 in InhA binding site, the B rings of these compounds 
are bound in a similar orientation and buried with the rigid residues 96-105, 148-168 and the 
pyrophosphate group of NAD+. The aromatic B ring of compound 22 interacts with the 
methyl side chain of Met161 to form the methyl- interaction, whereas that of compound 16 
loses this interaction. The hydroxyl group at the A ring of compounds 16 and 22 form two 
hydrogen bonds with Tyr158 as well as the 2´-hydroxyl group of NAD+. The substituents at 
the A rings of compounds 16 and 22, the ethyl phenyl and the octyl chain, respectively, are 
occupied with the flexible residues 195-225. The first four carbons of the octyl chain of 
compound 22 superimpose well with the ethyl phenyl of compound 16 and interact with the 
flexible residues of Phe149, Tyr158, Pro193, Met199, Ile215, Leu218, Glu219 and Trp222, 
respectively. The last four carbons of the octyl chain of compound 22 interact with Met155, 
Pro156, Ala157, Gln214, whereas these interactions are lost for binding of compound 16. The 
presence of the methyl- interaction and more interactions with the flexible residues 195-225 of 
the substituents at the A rings of compound 22 may be accounted for higher activity of 
compound 22 as compared with that of compound 16.  
3.2 Docking calculations of 5-substituted triclosan and alkyl diphenyl ether 
derivatives  
Molecular docking calculations using the Autodock 3.05 program have been successfully 
applied to investigate the binding modes of all 5-substituted triclosan and alkyl diphenyl 
ether derivatives in the InhA binding pocket. The RMSD between the docked and 
crystallographic conformations is lower than 1Å, indicating that molecular docking 
calculations are rendering high reliability for reproducing the binding mode of all 5-
substituted triclosan and alkyl diphenyl ether derivatives. All predicted binding modes of 
these inhibitors that are similar to the binding modes as those of the above X-ray crystal 
structures are shown in Fig. 3.  
The B rings are surrounded by the more rigid residues 96-105 and 148-168, whereas the A 
rings and their substituents are surrounded by the flexible residues 195-225. The hydroxyl 
groups at the A ring of all 5-substituted triclosan and alkyl diphenyl ether derivatives could 
create the same hydrogen bonding pattern with NAD+ and Tyr158. The major modification 
of 5-substituted triclosan and alkyl diphenyl ether derivatives is the variation of substituent 
R1 at the A ring. The increasing length of an alkyl chain at the substituent R1 results in the 
decreasing IC50 values for InhA inhibition of both 5-substituted triclosan and alkyl diphenyl 
ether derivatives, compounds 2, 4-6, 19-22. Compound 22 bearing the octyl chain at the A 
ring is the most active compound in the data set. To compare the binding modes of 
compounds containing alkyl chains of different lengths at the position R1, the predicted 
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binding modes of compounds 18-20 containing C6, C2 and C4 alkyl chains, respectively, are 
superimposed on the X-ray binding mode of compound 22 as shown in Fig. 4.  
 
 
Fig. 3. Superposition of all predicted binding modes of 5-substituted triclosan and alkyl 
diphenyl ether derivatives (green line) in InhA (pink) derived from molecular docking 
calculations and the X-ray structure of compound 22 (green stick) 
 
 
Fig. 4. The predicted binding modes of compounds 18 (yellow), 19 (green) and 20 (orange) 
containing C6, C2 and C4 chains at the substituent R1, respectively, and the X-ray binding 
mode of compound 22 (cyan) in the InhA binding pocket (cyan) 
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The longer octyl chain of compound 22 could more closely interact with α-helix residues 
200-225, whereas C6, C2 and C4 alkyl chains of compounds 18-20 are far from these 
residues, particularly the C2 alkyl chain of compound 19. This result may explain the higher 
activity of compound 22 bearing the longer alkyl chain at the position R1 as compared with 
those of compounds 18-20. However, when the octyl chain of compound 22 was enlarged to 
a C14 chain resulting in compound 23, there is a corresponding increase in IC50 value for 
InhA inhibition from 5 nM to 150 nM. In contrast to the C8 chain of compound 22 which lies 
in a linear conformation in InhA binding pocket, the C14 chain of compound 23 forms a U-
like shape within InhA binding pocket and slightly interacts with α-helix residues 200-225 as 
shown in Fig. 5. Moreover, the B ring of this compound loses the methyl- interaction with 
Met161. These results may be accounted for the lower potency of compound 23. In the case 
of compounds 13 and 14, where phenyl rings are directly attached to the A ring at position 
R1, the activity against InhA of these compounds are lower than those of compounds 15-17 
which have a linker between the A ring and the phenyl ring at substituent R1. Based on 
molecular docking calculations, the phenyl substituents of compounds 13 and 14 overlap 
with an ethyl linker of compound 16 and are surrounded by the rigid residues 148-168. To 
avoid the steric clash with these residues, a change of the binding conformation of 
compounds 13 and 14 has occurred, leading to a loss of the - stacking of the A ring with 
nicotinamide ring of NAD+ as compared with that of compound 16. Moreover, a linker 
phenyl substituent of compound 16 could create more hydrophobic interactions with the 
hydrophobic residues in the flexible residues 195-225. These results may explain why 
compounds 13 and 14 are of lower potency compared to compounds 15-17.  
 
 
Fig. 5. The predicted binding modes of compound 23 (pink) and the X-ray binding mode of 
compound 22 (cyan) in InhA binding pocket (cyan) 
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The presence of NO2 and NH2 groups at the B ring of the alkyl diphenyl ether derivatives 
giving compounds 24-29 results in lower activities (increasing of IC50 values) for InhA 
inhibition of these compounds as compared with that of compound 18. Based on molecular 
docking calculations, the A rings and hexyl substituents of compounds 24-29 overlap well 
with that of compound 18 as shown in Fig. 6. However, the NO2 and NH2 substituents at the 
B ring of compounds 24-29 induce the position change of B rings of these compounds to 
avoid the steric conflict with the rigid residues Gly96, Phe97, Met98, Met161 and the 
pyrophosphate group of NAD+. Because of this reorientation, the B rings of compounds 24-
29 lose the methyl- interaction with Met161 as compared with compound 27. Therefore, the 
lower activities against InhA of alkyl diphenyl ether derivatives which contain the NO2 and 
NH2 groups at the B ring may be a consequence of the loss of the methyl- interaction of the 
B rings of these compounds.   
 
 
Fig. 6. Superposition of the predicted binding modes of compounds 18 (yellow) and 24 
(green)  
3.3 CoMFA, CoMSIA and HQSAR models   
The results of the PLS analyses of CoMFA, CoMSIA and HQSAR models are summarized in 
Table 2. QSAR models 1, 3 and 5 derived from the PLS analyses of all compounds in the 
training set show a poor q2. To improve the quality of these QSAR models, compound 19 
was considered as an outlier resulting in better q2 values of models 2, 4 and 6. However, 
HQSAR model 6 still shows a poor q2 of 0.27. To modify this model, compounds 23 and 28 
were omitted from the training set which yields the satisfying HQSAR, model 7. Based on a 
good q2, models 2, 4 and 7 were selected as the final CoMFA, CoMSIA and HQSAR models, 
respectively. The final CoMFA model composing the steric and electrostatic fields gives q2 of 
0.66 and r2 of 0.99. In the case of the final CoMSIA model including the steric, electrostatic 
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and hydrophobic fields, a higher q2 value of 0.73 as compared with that of the final CoMFA 
model was obtained. This result indicates that the final CoMSIA model performs better in 
the prediction than the final CoMFA model, which is an indication for the fact that beyond 
steric and electrostatic effects, hydrogen bonding may be an additional contribution. Among 
the considered descriptors of the final CoMSIA and CoMFA models, the electrostatic fields 
of both models are the most important parameter influencing the IC50 values of the 5-
substituted triclosan and alkyl diphenyl ether derivatives in the training set. With regard to 
the best HQSAR model generated based on the combination of the different fragment types, 
atom (A), bond (B) and connection (C), this model shows q2 value of 0.74 with  r2 value of 
0.97 which are in the same level with those of the final CoMSIA model.  
 
Models Statistical parameters Fraction 
q2 r2 N s SEE F 
 CoMFA        
1   S/E 0.38 0.91 3 0.56 0.21 73.19 48/52 
2   S/E 0.66 0.99 6  0.05 698.63 39/61 
 CoMSIA         
3    S/E/H 0.45 0.89 4 0.54 0.24 39.27 24/46/30 
4    S/E/H 0.73 0.99 6  0.07 277.19 19/57/24 
 HQSAR        
5    A/B/C 0.14 0.32 1 0.63 0.56 - - 
6    A/B/C 0.27 0.43 1 0.54 0.47 - - 
7    A/B/C 0.74 0.97 6  0.12 - - 
Table 2. Summary of statistical results of CoMFA, CoMSIA and HQSAR models, N, 
optimum number of components; s, standard error of prediction, SEE, standard error of 
estimate; F, F-test value; S, steric field; E, electrostatic field; H, hydrophobic field;  A, atom; 
B, bond; C, connection  
3.4 Validation of the QSAR models  
Satisfyingly good correlations between actual and predicted activities of the training set 
based on the final CoMFA, CoMSIA and HQSAR models are depicted in Fig. 7. The 
predicted activities of the training set derived from the final QSAR models are close to the 
experimental activities indicating the high degree of correlation between the actual and 
predicted activities. In order to assess the external predictive ability of selected QSAR 
models, InhA inhibition activities of the test set were predicted. The IC50 values of test set 
compounds predicted by the final CoMFA, CoMSIA and HQSAR models are within one 
logarithmic unit difference from the experimental values except those of compound 2 as 
presented in Fig. 7. This result reveals that all selected QSAR models are reliable to predict 
the activity of external data set. Therefore, the final CoMFA, CoMSIA, and HQSAR models 
can be utilized for designing new direct InhA inhibitors with improved activity.  
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Fig. 7. Plots between the actual and predicted activities of the training and test sets derived 
from the final CoMFA (a), CoMSIA (b) and HQSAR (c) models, respectively 
3.5 CoMFA and CoMSIA contour maps 
To reveal the importance of molecular descriptor fields, steric, electrostatic and hydrophobic 
fields, on the InhA inhibition activities of 5-substituted triclosan and alkyl diphenyl ether 
derivatives, CoMFA and CoMSIA contour maps were established and depicted in Fig. 8 and 
9, respectively. CoMFA and CoMSIA contour maps are merged with the InhA pocket 
complexed with compounds 16 and 22 in order to link the structural requirement for better 
activity of 5-substituted triclosan and alkyl diphenyl ether derivatives visualized by CoMFA, 
CoMSIA contour maps toward the interaction of these compounds in InhA binding pocket. 
Green and yellow contours indicate areas where favorable and unfavorable steric bulks are 
predicted to enhance the antitubercular activities of the direct InhA inhibitors. Blue and red 
contours indicate regions where electropositive and electronegative groups lead to 
increasing antitubercular activity, respectively. Purple and white contours represent areas 
where the hydrophobic group and the hydrophilic group, are predicted to favour the 
biological activities. Compounds 16 and 22 were selected as the template for graphic 
interpretation of CoMFA and CoMSIA models. CoMFA model shows three yellow contours 
surrounding the B rings of compounds 16 and 22 buried in the pocket consisting of the rigid 
residues Gly96, Phe97, Met98, Met161 and NAD+ as shown in Fig. 8(a). These contours 
indicate that the substituent of the B ring should be small in order to increase the enzyme 
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(a) 
 
(b) 
Fig. 8. Steric and electrostatic contours of CoMFA (a) and CoMSIA (b) models in 
combination with compounds 16 (yellow) and 22 (orange) in InhA binding pocket (cyan). 
Green and yellow contours represent favourable and unfavourable steric regions, 
respectively. Blue and red contours are favoured for electropositive and electronegative 
groups, respectively. 
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inhibitory activity of 5-substituted triclosan and alkyl diphenyl ether derivatives. Moreover, 
this structural requirement is preferable for the interaction of the B ring with the rigid 
moiety consisting of residues Gly96, Phe97, Met98, Met161 and NAD+. In addition, the B 
rings of compounds 16 and 22 are covered by a large purple contour and immediately 
flanked by two white contours as shown in Fig. 9. A large purple region conforms to the 
aromatic B rings of 5-substituted triclosan and alkyl diphenyl ether derivatives which are 
crucial for the forming of the methyl- interaction with the methyl side chain of Met161. 
Furthermore, the presence of hydrophilic substituent with a small size at both sides of the B 
ring should enhance the activity against InhA of 5-substituted triclosan and alkyl diphenyl 
ether derivatives. 
 
 
Fig. 9. CoMSIA hydrophobic contours in combination with compounds 16 (yellow) and 22 
(orange) in InhA binding pocket (cyan). Purple and white contours show favourable and 
unfavourable hydrophobic regions, respectively. 
With regard to the substituent R1 of the A ring, CoMFA and CoMSIA models in Fig. 8 and 9 
present the large blue, white and yellow contours near the ethyl linker of compound 16 and 
the first two carbons of the octyl side chain of compound 22 which are surrounded by the 
rigid residues 148-168. These contours suggest that the blue, white and yellow regions near 
those of compounds 16 and 22 favor the small moiety with the electropositive and 
hydrophilic properties. It is important to note that this favored small moiety could be 
helpful not only for the activities against InhA of 5-substituted triclosan and alkyl diphenyl 
ether derivatives but also for the binding of these compounds at a position where rigid 
residues 148-168 are presented. This finding agrees well with the experimental data that 
compounds with no linker and the methyl linker between the A ring and the analogues of 
phenyl and pyridyl at substituent R1, compounds 10-15, show IC50 values higher than that of 
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compound 16 containing the ethyl linker. Based on the obtained molecular docking results, 
the analogues of bulky phenyl and pyridyl at substituent R1 of compounds 10-15 overlap 
with the ethyl linker of compound 16 located near the blue, white and yellow regions. 
Another interesting contour of CoMFA and CoMSIA models is the large green contour at 
the phenyl substituent of compound 16 and the last six carbons of the octyl chain of 
compound 22. The green contour indicates that the presence of the bulky substituent at this 
region should increase the InhA inhibitory activities of 5-substituted triclosan and alkyl 
diphenyl ether derivatives. This result is in line with the experimental results that 
compounds 1-2, 4-9, 19-21 presenting the shorter chain of substituent R1 display lower 
activities as compared with that of compound 22 bearing the longer octyl chain. 
Remarkably, based on the large green area, the combination between substituents R1 of                     
5-substituted triclosan derivatives and alkyl diphenyl ether derivatives, the phenyl 
substituent of compound 16 and the last six carbons of the octyl chain of compound 22, may 
generate the optimal substituent R1 such as the phenyl incorporated with alkyl chain. 
Therefore, the designed compounds should display the better profile against InhA. 
3.6 HQSAR contribution maps  
HQSAR contribution maps are helpful to visualize the contributions of molecular fragments 
to the activities against InhA of 5-substituted triclosan and alkyl diphenyl ether derivatives 
in the present data. The color codes indicate the different contributions of all atoms in each 
compound to the biological activity. An atom with negative contributions is represented at 
the red end of the spectrum, whereas an atom with positive contributions is represented at 
the green end of the spectrum. The white colored atoms stand for intermediate 
contributions. Fig. 10 depicts the individual atomic contributions to the activity against InhA 
of compounds 13, 16 and 22. There are green and yellow atoms at the A ring of compounds 
16 and 22 indicating the positive contributions of the A ring to the activity against InhA of 
these compounds. Moreover, the positive contributing fragments are presented at the ethyl 
linker of compound 16 and the first carbon of the octyl chain of compound 22 emphasizing 
the importance of these fragments. As previously shown by CoMFA and CoMSIA contours, 
these positively contributing moieties of compounds 16 and 22 are surrounded by yellow, 
blue and white contours implying that these fragments are optimal for steric, electrostatic 
and hydrophobic requirements. Obviously supporting this finding, the omission of the ethyl 
linker resulting in compound 13 induces the appearance of the negative contributing 
fragments at the A ring and the phenyl substituent leading to the lower activity of this 
compound as compared with that of compound 16. Considering the phenyl substituent of 
compound 16 and the last six carbons of the octyl chain of compound 22 buried in green 
CoMFA and CoMSIA contours as shown in Fig. 8, these fragments are colored by white 
indicating that these atoms have no contributions to the activity. Therefore, the modification 
of these white parts following the CoMFA and CoMSIA suggestions may improve the 
activity against InhA of 5-substituted triclosan and alkyl diphenyl ether derivatives. In case 
of the B rings of compounds 16 and 22, most atoms in the B ring and Cl substituents of 
compound 16 are colored by red and orange, suggesting the negative contributions of these 
fragments, whereas those of compound 22 are colored by white indicating no contribution 
of these fragments. This result may be accounted for the higher activity of compound 22 as 
compared with that of compound 16. Based on the obtained CoMFA and CoMSIA models, 
the B ring of compounds 16 and 22 are covered by a large purple contour and immediately 
flanked by two white contours. Therefore, the adjustment of the substituent at the B ring 
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based on the structural requirement suggested by CoMFA and CoMSIA models may induce 
the occurrence of the positive contribution on the B ring and its substituents resulting in the 
better activity against InhA. Noticeably, about the chlorine substituents at the B ring of 5-
substituted triclosan derivatives, the precence of a positively contributing fragment at the 
substituent R1 of the A ring induces the negative contribution on the chlorine substituents as 
shown by HQSAR contribution maps of compounds 13 and 16 in Fig. 10. This result implies 
that more interactions of substituent R1 of the A ring reduce the role of the B ring chlorines 
on the activities. Consistent with this finding, alkyl diphenyl ether derivatives without the B 
ring chlorines, compounds 18, 21 and 22, display activities against InhA higher than those of 
triclosan and its derivatives bearing the B ring chlorines, compounds 1-17. On the other 
hand, the B ring chlorines can be more preferable for the activities in case of compounds 
with less interactions of substituent R1 to InhA. As exemplified by compounds with shorter 
lenght of the alkyl chain (C2 and C4 chains at the substituent R1), compounds 19 and 20 
possess lower activites than those of compounds 4 and 6 containing the B ring chlorines. It is 
important to note that the influence of B ring chlorines on inhibitory activity of triclosan 
derivatives which is argued in Freundlich‘s work (Freundlich et al. 2009) and Sullivan’s 
work (Sullivan et al., 2006) could be evaluated by our HQSAR model.  
 
 
 
 
(a) (b) 
 
 
 
(c) 
Fig. 10. The final HQSAR contribution maps of compounds 13 (a), 16 (b) and 22 (c)  
4. Conclusion  
Molecular docking calculations were successfully applied to determine the potential binding 
modes of 5-substituted triclosan and alkyl diphenyl ether derivatives in the InhA binding 
pocket. The B rings of these compounds are occupied in the rigid pocket consisting of 
residues 96-105 and 148-168, whereas the A rings and their substituents are buried in the 
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flexible residues 195-225. The B ring substituents that could perturb the methyl- interaction 
of the B ring with Met161 produce the poor activities of alkyl diphenyl ether derivatives. On 
the other hand, the substituent R1 at the A ring that could interact more with the flexible 
residues 195-225 and avoid the steric conflict with the rigid residues 148-168 might result in 
the better activities of 5-substituted triclosan and alkyl diphenyl ether derivatives against 
InhA. Besides, the key structural elements for a good activity against InhA of these 
compounds based on CoMFA, CoMSIA and HQSAR were clearly elucidated in the present 
study. Based on CoMFA and CoMSIA guidelines, compounds with the combination of 
substituents R1 of 5-substituted triclosan derivatives and alkyl diphenyl ether derivatives 
should display the better profile against InhA. In agreement with CoMFA and CoMSIA 
results, the HQSAR contribution maps show the individual contribution of the atoms to IC50 
values of 5-substituted triclosan and alkyl diphenyl ether derivatives. Moreover, HQSAR 
contribution maps could reveal the contribution of two chlorine atoms on the B ring of 5-
substituted triclosan derivatives to their IC50 values. Consequently, the integrated results 
from the structure-based design using molecular docking calculations and the ligand-based 
design using various QSAR approaches provide insights into key structural features that 
can be utilized for designing novel and more active InhA inhibitors in the series of 5-
substituted triclosan and alkyl diphenyl ether derivatives. Particularly, the modified 
compound suggested in the present study might be a member of a next drug generation of 
InhA inhibitor. These results demonstrate that computer aided molecular design approaches 
are fruitful for rational design and for possible syntheses of novel and more active InhA 
inhibitors that might be next generation of antitubercular agents.  
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